This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
RH (RH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
RH (RH) delivered earnings and revenue surprises of -8.15% and -0.70%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
RHNegative Net Change PEPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Adobe Systems (ADBE) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Adobe (ADBE) delivered earnings and revenue surprises of +2.71% and +1.50%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
ADBENegative Net Change PRGSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Why Flexsteel (FLXS) Might be Well Poised for a Surge
by Zacks Equity Research
Flexsteel Industries (FLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FLXSNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
What Makes Unilever (UL) a New Buy Stock
by Zacks Equity Research
Unilever (UL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ULNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
atai Life Sciences (ATAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ATAIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
First Commonwealth Financial (FCF) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
First Commonwealth Financial (FCF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
FCFNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Stevanato (STVN) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Stevanato (STVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
STVNNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Primoris Services (PRIM) Upgraded to Buy: Here's Why
by Zacks Equity Research
Primoris Services (PRIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PRIMNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Posco (PKX) Rating Upgrade to Buy
by Zacks Equity Research
Posco (PKX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PKXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Sphere 3D (ANY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Sphere 3D (ANY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ANYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Astria Therapeutics (ATXS) Rating Upgrade to Buy
by Zacks Equity Research
Astria Therapeutics (ATXS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ATXSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Vontier (VNT) a New Buy Stock
by Zacks Equity Research
Vontier (VNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
VNTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Modine (MOD) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Modine (MOD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MODPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report?
by Zacks Equity Research
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
EDITNegative Net Change GSKNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is H&R Block (HRB) Up 0.6% Since Last Earnings Report?
by Zacks Equity Research
H&R Block (HRB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HRBNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TBPHPositive Net Change UTHRPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Earnings Growth & Price Strength Make Quanta Services (PWR) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
PWRNegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Vera Bradley (VRA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Vera Bradley (VRA) delivered earnings and revenue surprises of +86.67% and -9.76%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
VRAPositive Net Change LEVINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kroger (KR) Tops Q2 Earnings Estimates
by Zacks Equity Research
Kroger (KR) delivered earnings and revenue surprises of +4.00% and -0.54%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
KRPositive Net Change SFIXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lovesac (LOVE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Lovesac (LOVE) delivered earnings and revenue surprises of +37.50% and -0.20%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
LOVENegative Net Change AZONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
KalVista Pharmaceuticals, Inc. (KALV) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
KalVista Pharmaceuticals (KALV) delivered earnings and revenue surprises of -23.08% and -20.91%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
KALVNegative Net Change NRIXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hooker Furniture (HOFT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Hooker Furniture (HOFT) delivered earnings and revenue surprises of -158.33% and -9.89%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
HOFTNegative Net Change BSETNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Culp, Inc. (CULP) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Culp (CULP) delivered earnings and revenue surprises of +83.33% and -11.84%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
CULPPositive Net Change LGCYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lesaka Technologies (LSAK) Q4 Earnings Beat Estimates
by Zacks Equity Research
Lesaka Technologies (LSAK) delivered earnings and revenue surprises of +25.00% and -37.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LSAKPositive Net Change BYRNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Oxford Industries (OXM) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Oxford Industries (OXM) delivered earnings and revenue surprises of +4.13% and -1.11%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
OXMNegative Net Change MTNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank